MXPA03008089A - Compuestos heterociclicos para complicaciones relacionadas con el envejecimiento y vasculares diabeticas. - Google Patents
Compuestos heterociclicos para complicaciones relacionadas con el envejecimiento y vasculares diabeticas.Info
- Publication number
- MXPA03008089A MXPA03008089A MXPA03008089A MXPA03008089A MXPA03008089A MX PA03008089 A MXPA03008089 A MX PA03008089A MX PA03008089 A MXPA03008089 A MX PA03008089A MX PA03008089 A MXPA03008089 A MX PA03008089A MX PA03008089 A MXPA03008089 A MX PA03008089A
- Authority
- MX
- Mexico
- Prior art keywords
- discloses
- age
- compounds
- vascular complications
- aging
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/10—Anti-acne agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/16—Emollients or protectives, e.g. against radiation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/12—Ophthalmic agents for cataracts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/06—Free radical scavengers or antioxidants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/06—Antianaemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US28138001P | 2001-04-05 | 2001-04-05 | |
PCT/IB2002/001137 WO2002085897A1 (en) | 2001-04-05 | 2002-04-02 | Heterocyclic compounds for aging-related and diabetic vascular complications |
Publications (1)
Publication Number | Publication Date |
---|---|
MXPA03008089A true MXPA03008089A (es) | 2004-01-22 |
Family
ID=23077044
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MXPA03008089A MXPA03008089A (es) | 2001-04-05 | 2002-04-02 | Compuestos heterociclicos para complicaciones relacionadas con el envejecimiento y vasculares diabeticas. |
Country Status (22)
Country | Link |
---|---|
US (2) | US7223777B2 (es) |
EP (1) | EP1373263B1 (es) |
JP (2) | JP4485744B2 (es) |
KR (1) | KR100785109B1 (es) |
CN (1) | CN1259316C (es) |
AT (1) | ATE280766T1 (es) |
AU (1) | AU2002253432B2 (es) |
BR (1) | BR0208561A (es) |
CA (1) | CA2439593C (es) |
CZ (1) | CZ20032013A3 (es) |
DE (1) | DE60201740T2 (es) |
DK (1) | DK1373263T3 (es) |
ES (1) | ES2231685T3 (es) |
HK (1) | HK1061234A1 (es) |
HU (1) | HUP0400823A3 (es) |
MX (1) | MXPA03008089A (es) |
PL (1) | PL365441A1 (es) |
PT (1) | PT1373263E (es) |
RU (1) | RU2291154C2 (es) |
SI (1) | SI1373263T1 (es) |
WO (1) | WO2002085897A1 (es) |
ZA (1) | ZA200306370B (es) |
Families Citing this family (54)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
MXPA03005954A (es) * | 2000-12-29 | 2004-05-24 | Alteon Inc | Metodo para tratar enfermedades fibroticas u otras indicaciones iiic. |
WO2002085897A1 (en) * | 2001-04-05 | 2002-10-31 | Alangudi Sankaranarayanan | Heterocyclic compounds for aging-related and diabetic vascular complications |
ZA200505734B (en) * | 2003-02-07 | 2006-12-27 | Daiichi Seiyaku Co | Pyrazole Derivative |
KR20050096956A (ko) | 2003-02-07 | 2005-10-06 | 다이이찌 세이야꾸 가부시기가이샤 | 피라졸 유도체 |
US7932272B2 (en) | 2003-09-30 | 2011-04-26 | Eisai R&D Management Co., Ltd. | Antifungal agent containing heterocyclic compound |
US7354938B2 (en) * | 2004-03-23 | 2008-04-08 | Amgen Inc. | Pyrazole compounds and uses related thereto |
US20050241110A1 (en) * | 2004-04-09 | 2005-11-03 | Bruce Baker | Ergonomic handles, especially for garden tools |
WO2006002983A1 (en) * | 2004-07-06 | 2006-01-12 | Novartis Ag | Combination of organic compounds |
JPWO2006016548A1 (ja) * | 2004-08-09 | 2008-05-01 | エーザイ・アール・アンド・ディー・マネジメント株式会社 | ヘテロ環化合物を含有する新規な抗マラリア剤 |
US8710038B2 (en) | 2004-09-17 | 2014-04-29 | Exelixis, Inc. | Pyrazole kinase modulators and methods of use |
NZ589670A (en) | 2004-12-20 | 2013-01-25 | Genentech Inc | Pyrrolidine inhibitors of iap |
EP1858499A4 (en) * | 2005-02-24 | 2010-03-03 | Univ Washington | METHODS OF TREATING RETINAL DEGENERATIVE DISEASE |
EP1864980A4 (en) | 2005-03-30 | 2010-08-18 | Eisai R&D Man Co Ltd | A PYRIDINE DERIVATIVE ANTIPILIC AGENT |
CN101300250B (zh) * | 2005-10-31 | 2012-09-05 | 卫材R&D管理有限公司 | 杂环取代吡啶衍生物及含有该衍生物的抗真菌剂 |
TWI385169B (zh) | 2005-10-31 | 2013-02-11 | Eisai R&D Man Co Ltd | 經雜環取代之吡啶衍生物及含有彼之抗真菌劑 |
EP1944303B1 (en) | 2005-10-31 | 2013-08-21 | Eisai R&D Management Co., Ltd. | Pyridine derivative substituted by heterocycle and fungicide containing the same |
SA07280004B1 (ar) | 2006-02-02 | 2011-10-29 | استرازينيكا ايه بي | ملح سترات من مركب 2- هيدروكسي –3- [5- (مورفولين –4- يل ميثيل) بيريدين –2- يل] 1h- إندول –5- كربونيتريل سترات |
RS20090036A (en) * | 2006-07-05 | 2010-06-30 | Pfizer Products Inc. | Pyrazole derivatives as cytochrom p450 inhibitors |
WO2008035726A1 (fr) | 2006-09-21 | 2008-03-27 | Eisai R & D Management Co., Ltd. | Dérivé de pyridine substitué par un cycle hétéroaryle, et agent antifongique le comprenant |
AU2007325350B2 (en) | 2006-11-29 | 2012-09-20 | Abbvie Inc. | Inhibitors of diacylglycerol O-acylotransferase type 1 enzyme |
US20080312169A1 (en) * | 2007-03-20 | 2008-12-18 | Clarence Albert Johnson | Cosmetic use of D-ribose |
US20090197819A1 (en) * | 2007-03-20 | 2009-08-06 | Clarence Albert Johnson | Compositions for improving and repairing skin |
TW200841879A (en) * | 2007-04-27 | 2008-11-01 | Eisai R&D Man Co Ltd | Pyridine derivatives substituted by heterocyclic ring and phosphonoamino group, and anti-fungal agent containing same |
CA2685194A1 (en) * | 2007-04-27 | 2008-11-13 | Eisai R&D Management Co., Ltd. | Heterocycle-substituted pyridine derivatives salt or crystal thereof |
TWI432212B (zh) * | 2007-04-30 | 2014-04-01 | Genentech Inc | Iap抑制劑 |
FR2918570B1 (fr) * | 2007-07-09 | 2012-10-05 | Engelhard Lyon | DIGLYCATION DES AGEs. |
EP3725309B1 (en) * | 2007-09-26 | 2022-11-23 | Indiana University Research & Technology Corporation | Benzoquinone derivative e3330 for the treatment of eye diseases |
RU2474581C2 (ru) * | 2007-12-26 | 2013-02-10 | Эйсай Ар Энд Ди Менеджмент Ко., Лтд. | Способ получения замещенных гетероциклом производных пиридина |
US8513287B2 (en) | 2007-12-27 | 2013-08-20 | Eisai R&D Management Co., Ltd. | Heterocyclic ring and phosphonoxymethyl group substituted pyridine derivatives and antifungal agent containing same |
KR100989093B1 (ko) | 2008-01-18 | 2010-10-25 | 한화제약주식회사 | 생강나무 가지의 추출물을 포함하는 심혈관계 질환의 예방 및 치료용 조성물 |
WO2009093264A2 (en) * | 2008-01-25 | 2009-07-30 | Torrent Pharmaceuticals Ltd. | Pharmaceutical combinations |
US20090232750A1 (en) * | 2008-03-13 | 2009-09-17 | St Cyr John A | Compositions for indoor tanning |
EP2318395A4 (en) | 2008-08-02 | 2011-10-26 | Genentech Inc | IPA INHIBITORS |
WO2010032874A1 (ja) * | 2008-09-19 | 2010-03-25 | 住友化学株式会社 | 農業用組成物 |
EP2346505B1 (en) * | 2008-10-16 | 2014-04-23 | Janssen Pharmaceuticals, Inc. | Indole and benzomorpholine derivatives as modulators of metabotropic glutamate receptors |
US8188119B2 (en) | 2008-10-24 | 2012-05-29 | Eisai R&D Management Co., Ltd | Pyridine derivatives substituted with heterocyclic ring and γ-glutamylamino group, and antifungal agents containing same |
EA201171368A1 (ru) * | 2009-05-07 | 2012-04-30 | Торрент Фармасьютикалз Лимитед | Новые гетероциклические соединения |
KR101040162B1 (ko) * | 2009-05-12 | 2011-06-09 | 주식회사 카모스 | 감시카메라의 브라켓 |
WO2011051198A2 (de) | 2009-10-30 | 2011-05-05 | Bayer Cropscience Ag | Pyridin-derivate als pflanzenschutzmittel |
KR101018881B1 (ko) * | 2009-11-03 | 2011-03-04 | 주식회사 엑스트론아이앤티 | 감시카메라용 브라켓 |
CA2793859C (en) * | 2010-04-28 | 2018-02-13 | Toray Industries, Inc. | Therapeutic agent and preventative agent for alzheimer's disease |
WO2012020738A1 (ja) * | 2010-08-09 | 2012-02-16 | 武田薬品工業株式会社 | 複素環化合物およびその用途 |
DK2968249T3 (en) | 2013-02-22 | 2019-03-04 | Samumed Llc | GAMMA DIKETONS AS WNT / BETA-CATENIN SIGNAL ROAD ACTIVATORS |
US9226890B1 (en) | 2013-12-10 | 2016-01-05 | Englewood Lab, Llc | Polysilicone base for scar treatment |
KR101898364B1 (ko) * | 2014-05-22 | 2018-09-12 | 에프. 호프만-라 로슈 아게 | 인돌린-2-온 및 1,3-다이하이드로-피롤로[3,2-c]피리딘-2-온 유도체 |
BR112017003959B1 (pt) | 2014-08-20 | 2022-08-02 | Samumed, Llc | Uso de um composto de fórmula i ou um sal dermatologicamente aceitável do mesmo |
FR3026947B1 (fr) * | 2014-10-10 | 2017-12-08 | Basf Beauty Care Solutions France Sas | Activite deglycation d'une combinaison d'un extrait de salvia miltiorrhiza et de niacine et/ou de niacinamide |
MY182914A (en) | 2015-04-08 | 2021-02-05 | Torrent Pharmaceuticals Ltd | Pyridinium compounds |
CN106806886B (zh) * | 2015-12-01 | 2021-07-16 | 华中科技大学 | 一种快速消除口臭的口气清新剂及其医药用途 |
MA51052A (fr) | 2017-12-07 | 2021-04-21 | Amplyx Pharmaceuticals Inc | Agents antifongiques dérivés de pyridine substitués par un hétérocycle |
CN108157405B (zh) * | 2018-02-06 | 2020-10-02 | 上海应用技术大学 | 一种灭蟑螂饵剂及其制备方法和应用 |
CA3104653A1 (en) * | 2018-06-25 | 2020-01-02 | Amplyx Pharmaceuticals, Inc. | Pyridine derivatives substituted by heterocyclic ring and amino group |
CA3121202A1 (en) | 2018-11-30 | 2020-06-04 | Nuvation Bio Inc. | Pyrrole and pyrazole compounds and methods of use thereof |
DE202022104072U1 (de) | 2022-07-19 | 2022-07-29 | Siva Subramanian Narayanasamy | Heterozyklisch substituierte pyridinderivate antimykotische Mittel |
Family Cites Families (24)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3501484A (en) * | 1968-01-15 | 1970-03-17 | Miles Lab | Certain substituted 3 - (2-indolyl)-1,2,5,6-tetrahydropyridines and derivatives thereof |
US3501312A (en) * | 1968-07-22 | 1970-03-17 | Eastman Kodak Co | Direct positive silver halide emulsions containing trimethine cyanine dyes |
US3957805A (en) * | 1974-07-24 | 1976-05-18 | American Cyanamid Company | Substituted pyridines and diazines and methods of preparing the same |
US5137916A (en) | 1985-11-14 | 1992-08-11 | The Rockefeller University | Advanced glycation inhibitors containing amino-benzoic acids and derivatives, and methods of use |
US5514676A (en) | 1984-03-19 | 1996-05-07 | The Rockefeller University | Amino-benzoic acids and derivatives, and methods of use |
US5272176A (en) | 1984-03-19 | 1993-12-21 | The Rockefeller University | Advanced glycation inhibitors containing amino-benzoic acids and derivatives, and methods of use |
US4758583A (en) | 1984-03-19 | 1988-07-19 | The Rockefeller University | Method and agents for inhibiting protein aging |
GB8714789D0 (en) * | 1987-06-24 | 1987-07-29 | Lundbeck & Co As H | Heterocyclic compounds |
EP0339496A3 (en) | 1988-04-26 | 1991-05-08 | Ono Pharmaceutical Co., Ltd. | Aminoguanidine derivatives |
US5330994A (en) * | 1992-03-24 | 1994-07-19 | Warner-Lambert Company | Tetrahydropyridine isoxazoline derivatives |
DE4210502A1 (de) * | 1992-03-31 | 1993-10-07 | Bayer Ag | Verwendung von 3-aminosubstituierten Isoxazolderivaten zur Bekämpfung von Endoparasiten, neue 3-aminosubstituierte Isoxazolderivate und Verfahren zu ihrer Herstellung |
US5656261A (en) | 1995-01-18 | 1997-08-12 | The Picower Institute For Medical Research | Preventing and reversing advanced glycosylation endproducts |
EP0808163B1 (en) | 1995-01-18 | 2003-07-23 | Alteon, Inc. | Use of thiazolium compounds for preventing and reversing the formation of advanced glycosylation endproducts |
US6228858B1 (en) * | 1995-09-12 | 2001-05-08 | University Of Kansas Medical Center | Advanced glycation end-product intermediaries and post-amadori inhibition |
JPH09291082A (ja) * | 1996-02-27 | 1997-11-11 | Sankyo Co Ltd | イソキサゾール誘導体 |
AU7553198A (en) * | 1997-06-12 | 1998-12-30 | Sumitomo Pharmaceuticals Company, Limited | Pyrazole derivatives |
AU3512400A (en) * | 1999-03-05 | 2000-09-21 | Kansas University Medical Center | Novel post-amadori inhibitors of advanced glycation reactions |
US20010044445A1 (en) * | 1999-04-08 | 2001-11-22 | Bamaung Nwe Y. | Azole inhibitors of cytokine production |
AU4671100A (en) * | 1999-04-30 | 2000-11-17 | City Of Hope | Method of inhibiting glycation product formation |
FR2796278B1 (fr) | 1999-07-16 | 2002-05-03 | Oreal | Utilisation d'au moins un hydroxystilbene comme agent anti-glycation |
MXPA02003496A (es) * | 1999-10-06 | 2005-06-20 | Torrent Pharmaceuticals Ltd | Derivados de piridinio para el tratamiento de complicaciones vasculares diabeticas y relacionadas con la edad. |
ATE260256T1 (de) * | 1999-10-06 | 2004-03-15 | Torrent Pharmaceuticals Ltd | Pyridinium-derivate zur behandlung von altersbedingten und diabetischen vaskulären komplikationen, verfahren zu ihrer herstellung und ihre pharmazeutischen anwendungen |
FR2802420B1 (fr) | 1999-12-21 | 2002-02-22 | Oreal | Utilisation du 3,3', 5,5'-tetrahydroxystilbene comme agent anti-glycation |
WO2002085897A1 (en) * | 2001-04-05 | 2002-10-31 | Alangudi Sankaranarayanan | Heterocyclic compounds for aging-related and diabetic vascular complications |
-
2002
- 2002-04-02 WO PCT/IB2002/001137 patent/WO2002085897A1/en active IP Right Grant
- 2002-04-02 AU AU2002253432A patent/AU2002253432B2/en not_active Ceased
- 2002-04-02 ES ES02722547T patent/ES2231685T3/es not_active Expired - Lifetime
- 2002-04-02 CN CNB028069803A patent/CN1259316C/zh not_active Expired - Fee Related
- 2002-04-02 CA CA2439593A patent/CA2439593C/en not_active Expired - Fee Related
- 2002-04-02 SI SI200230069T patent/SI1373263T1/xx unknown
- 2002-04-02 MX MXPA03008089A patent/MXPA03008089A/es active IP Right Grant
- 2002-04-02 AT AT02722547T patent/ATE280766T1/de not_active IP Right Cessation
- 2002-04-02 HU HU0400823A patent/HUP0400823A3/hu unknown
- 2002-04-02 KR KR1020037012877A patent/KR100785109B1/ko not_active IP Right Cessation
- 2002-04-02 JP JP2002583424A patent/JP4485744B2/ja not_active Expired - Fee Related
- 2002-04-02 DE DE60201740T patent/DE60201740T2/de not_active Expired - Lifetime
- 2002-04-02 EP EP02722547A patent/EP1373263B1/en not_active Expired - Lifetime
- 2002-04-02 DK DK02722547T patent/DK1373263T3/da active
- 2002-04-02 PL PL02365441A patent/PL365441A1/xx not_active Application Discontinuation
- 2002-04-02 BR BR0208561-5A patent/BR0208561A/pt not_active IP Right Cessation
- 2002-04-02 CZ CZ20032013A patent/CZ20032013A3/cs unknown
- 2002-04-02 RU RU2003128076/04A patent/RU2291154C2/ru not_active IP Right Cessation
- 2002-04-02 PT PT02722547T patent/PT1373263E/pt unknown
- 2002-04-05 US US10/116,135 patent/US7223777B2/en not_active Expired - Fee Related
-
2003
- 2003-08-15 ZA ZA200306370A patent/ZA200306370B/en unknown
-
2004
- 2004-06-11 HK HK04104243A patent/HK1061234A1/xx not_active IP Right Cessation
-
2007
- 2007-03-29 US US11/727,909 patent/US20070167493A1/en not_active Abandoned
-
2009
- 2009-12-25 JP JP2009295336A patent/JP2010100640A/ja active Pending
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1061234A1 (en) | Heterocyclic compounds for aging-related and diabetic vascular complications. | |
JO2353B1 (en) | New derivatives of mixed-ring fluoroglycosides and drugs containing these compounds and their use | |
UA74346C2 (uk) | Похідні амінодикарбонових кислот, їх застосування та лікарський засіб | |
NO20051600L (no) | 1,4-disubstituerte piperidinderivater og anvendelse derav som 11-betaHSD1 inhibitorer | |
BRPI0415437A (pt) | composto, processo para a preparação e uso do mesmo, composição farmacêutica, processo para a preparação da mesma, e, produto | |
NO20056030L (no) | Nye pyridopyraziner og anvendelse derav som kinaseinhibitorer | |
NO20053644L (no) | (2S)-2-[(4S)-4-(2,2-difluorvinyl)-2-oksopyrrolidinyl ]butanamid og farmasoytisk preparat | |
BG106825A (en) | Substituted oxazolidinones and their use in the field of blood coagulation | |
NO20070576L (no) | Nye hydantionderivater for behandling av obstruktive luftveissykdommer. | |
BR0309343A (pt) | Composto, composição farmacêutica, uso de um composto, e, método de tratamento ou profilaxia de doenças ou condições humanas | |
NO20052182L (no) | Nye forbindelser | |
BR0309342A (pt) | Composto, composição farmacêutica, uso de um composto, e, método de tratamento ou profilaxia de doenças ou condições humanas | |
NZ536750A (en) | 7-Aryl-3,9-diazabicyclo (3.3.1)non-6-ene derivatives and their use as renin inhibitors in the treatment of hypertension, cardiovascular or renal diseases | |
AU3850600A (en) | Dalda analogs and their use | |
ATE406353T1 (de) | Piperidin-derivaten und deren verwendung bei der behandlung von durch chemokinen oder h1 vermittelten krankheiten | |
PL1682528T3 (pl) | Pochodne benzo[b][1,4]dioksepiny | |
DE60315032D1 (de) | Phenylalanin enamidderivate | |
AU1185801A (en) | Novel compounds | |
DE59904875D1 (de) | Substituierte phenyl-alkenoylguanidine, verfahren zu ihrer herstellung, ihre verwendung als medikamente oder diagnostika sowie sie enthaltende medikamente | |
ATE422892T1 (de) | Verwendung von hyaluronsäure zur herstellung von zusammensetzungen zur behandlung rekurrenten aphthen in der mundhöhle | |
NO20026081L (no) | Nye forbindelser | |
WO2002055491A3 (en) | 1,2-DISUBSTITUTED CYCLIC INHIBITORS OF MATRIX METALLORPROTEASES AND TNF-$g(a) | |
HRP20050667A2 (en) | Corbonyl-amino substituted acyl phenyl urea derivatives, method for the production and use thereof | |
AU2003226709A1 (en) | Organosilicone derivatives of amino hydroxybenzophenones and their use as uv-a filters in cosmetic preparations | |
NO20044531L (no) | Imidazolinylmetyl-aralkylsulfonamider, blandinger omfattende slike, fremgangsmate for fremstilling av slike, slike forbindelser som medikament samt anvendelse av slike forbindelser for fremstilling av medikamenter for behandling av sykdom |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG | Grant or registration |